Adolore Biotherapeutics, Inc.

BRIEF

published on 10/02/2024 at 16:05, 1 month 19 days ago

Adolore BioTherapeutics présentera ses travaux au 18e Sommet annuel sur les thérapies contre la douleur

Adolore BioTherapeutics Traitements De La Douleur Chronique Alternatives Aux Opioïdes 18e Sommet Annuel Sur Les Thérapies Contre La Douleur Peptides Analgésiques CA8*
BRIEF

published on 10/02/2024 at 16:05, 1 month 19 days ago

Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit

Adolore BioTherapeutics Chronic Pain Treatments Opioid Alternatives 18th Annual Pain Therapeutics Summit CA8* Analgesic Peptides
PRESS RELEASE

published on 10/02/2024 at 16:00, 1 month 19 days ago

Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit
Adolore BioTherapeutics to present innovative opioid-free chronic pain treatments at the 18th Annual Pain Therapeutics Summit in Boston, Ma, based on cutting-edge CA8* analgesic peptides & rdHSV vectors technology

Adolore BioTherapeutics Opioid-free Chronic Pain Treatments CA8 Peptides RdHSV Vectors
BRIEF

published on 09/24/2024 at 14:25, 1 month 27 days ago

Adolore BioTherapeutics présentera son projet lors de l'événement Pitch de BioSparkVA

Adolore BioTherapeutics Douleur Chronique BioSparkVA Roy C. Levitt Thérapie Non Opioïde
BRIEF

published on 09/24/2024 at 14:25, 1 month 27 days ago

Adolore BioTherapeutics to Present at BioSparkVA Pitch Event

Adolore BioTherapeutics Chronic Pain Non-opioid Therapy BioSparkVA Roy C. Levitt
PRESS RELEASE

published on 09/24/2024 at 14:20, 1 month 27 days ago

Adolore BioTherapeutics to Present at BioSparkVA Pitch Event
Adolore BioTherapeutics to present innovative opioid-free chronic pain therapy at BioSpark Pitch Event. Programs for knee osteoarthritis & erythromelalgia in development

Adolore BioTherapeutics Chronic Pain Opioid-free Biotherapeutics Innovative Therapy
BRIEF

published on 07/30/2024 at 14:15, 3 months 22 days ago

Adolore BioTherapeutics Publishes Promising Preclinical Data on Non-Opioid Analgesic Gene Therapy

Adolore BioTherapeutics Chronic Pain Gene Therapy Osteoarthritis Non-opioid Analgesic
BRIEF

published on 07/30/2024 at 14:15, 3 months 22 days ago

Adolore BioTherapeutics publie des données précliniques prometteuses sur la thérapie génique analgésique non opioïde

Adolore BioTherapeutics Thérapie Génique La Douleur Chronique Analgésique Non Opioïde Arthrose
PRESS RELEASE

published on 07/30/2024 at 14:10, 3 months 22 days ago

Adolore BioTherapeutics Announces Publication of Compelling Preclinical Efficacy and Safety Data Supporting Adolore's Non-opioid Analgesic Gene Therapy, ADLR-1001, For Treatment of Moderate to Severe Chronic Knee Pain Due to Osteoarthritis (OA)
Adolore BioTherapeutics validates a non-opioid analgesic gene therapy for chronic pain via local delivery to sensory neurons. Preclinical study supports opioid-free treatment for chronic knee pain due to OA

Adolore BioTherapeutics Chronic Pain Gene Therapy Non-opioid Analgesic Opioid-free Treatment
BRIEF

published on 06/10/2024 at 15:20, 5 months 11 days ago

Adolore BioTherapeutics fera une présentation à la conférence virtuelle de présentation des investisseurs

Adolore BioTherapeutics Thérapie Génique Traitement De La Douleur Chronique Conférence Virtuelle De Présentation Des Investisseurs Sans Opioïdes

Published on 11/21/2024 at 16:30, 23 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 52 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 53 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 53 minutes ago

Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 53 minutes ago

Isaac Ullatil Joins Wellstack Board of Directors

View all ACCESSWIRE

Published on 11/21/2024 at 16:00, 53 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 1 hour 11 minutes ago

Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 1 hour 29 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 1 hour 30 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 1 hour 31 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc

View all EQS

Published on 11/21/2024 at 06:58, 9 hours 55 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 55 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 55 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 20 hours 46 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 21 hours 33 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE

News